Remifentanil for abdominal surgery is associated with unexpectedly unfavorable outcomes. Niedermayer S, Heyn J, Guenther F, Kuchenhoff H, et al. Pain 2020;161:266-273.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Niedermayer S, Heyn J, Guenther F, Kuchenhoff H, et al. Remifentanil for abdominal surgery is associated with unexpectedly unfavorable outcomes. Pain 2020;161:266-273.
PMID: 31592999